Molson Coors Acquires Stake in Cocktail Mixers Maker Fever-Tree

The deal gives the brewer exclusive commercialization rights for Fever-Tree’s U.S. lineup.

Screenshot 2025 01 31 At 10 30 44 Am
Business Wire

Molson Coors on Thursday announced a strategic partnership with U.K. cocktail mixers maker Fever-Tree — including the acquisition of a minority stake in the company.

Under the agreement, the brewer will assume exclusive commercialization rights to Fever-Tree’s lineup of tonics, ginger beers, cocktail mixers and more in the U.S., effective Saturday. Molson Coors will also be responsible for co-manufactured production, marketing, sales and distribution of the brand in the U.S.

Molson Coors officials called the move a "significant step forward" in its efforts to build "a total-beverage portfolio" across both traditional alcoholic beverages and non-alcoholic options.

“Our strategic partnership with Fever-Tree in the U.S. is a meaningful step in Molson Coors’ journey to becoming a total-beverage company with a winning portfolio of drinks for a wide variety of consumer occasions. We’ve made progress here, and today we are building on that progress in a significant way with Fever-Tree as the latest and largest non-alc brand to join our portfolio,” Molson Coors CEO Gavin Hattersley said in a statement. “The U.S. is our biggest global market by revenue, and the same is true for Fever-Tree, so we believe this partnership provides ample opportunity for our teams to build on the strong success Fever-Tree has achieved to date."

Molson Coors indicated that it plans to build on the position Fever-Tree has already established in the U.S. by leveraging its core strengths, commercial scale and supply chain expertise to expand distribution and grow the brand.

The company has agreed to acquire an 8.5% stake in Fevertree Drinks plc, resulting in Molson Coors becoming Fever-Tree’s second-largest shareholder.

“Today’s announcement marks a transformational step for the Fever-Tree brand in the U.S. and is not only a reflection of how far we have come since first entering the market in 2008 but also how the opportunity ahead for the brand continues to grow,” said Fever-Tree CEO Tim Warrillow. “With a national network providing scale and muscle, proven track record, supply chain expertise and clearly stated strategic desire to drive the future of their business beyond beer, Molson Coors are the ideal partner to take the Fever-Tree brand to the next level across the U.S.”

More in Capital Investment